BerandaBRNS • NASDAQ
add
Barinthus Biotherapeutics PLC - ADR
Tutup sebelumnya
$1,14
Rentang hari
$1,00 - $1,14
Rentang tahun
$0,81 - $4,16
Kapitalisasi pasar
41,44Â jt USD
Volume Rata-Rata
52,45Â rb
Bursa utama
NASDAQ
Dalam berita
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 14,97 jt | — |
Biaya operasional | 23,72Â jt | 49,31% |
Laba bersih | -8,11Â jt | 42,34% |
Margin laba bersih | -54,21 | — |
Penghasilan per saham | -0,21 | 43,24% |
EBITDA | -8,48Â jt | 41,43% |
Tarif pajak efektif | 0,04% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 106,10Â jt | -33,81% |
Total aset | 188,69Â jt | -17,95% |
Total liabilitas | 29,23Â jt | -14,95% |
Total ekuitas | 159,46 jt | — |
Saham yang beredar | 40,23 jt | — |
Harga terhadap nilai buku | 0,28 | — |
Tingkat pengembalian aset | -12,19% | — |
Tingkat pengembalian modal | -13,40% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -8,11Â jt | 42,34% |
Kas dari operasi | -18,20Â jt | -62,61% |
Kas dari investasi | -114,00Â rb | -216,67% |
Kas dari pembiayaan | 465,00Â rb | 910,87% |
Perubahan kas bersih | -11,67Â jt | 8,25% |
Arus kas bebas | -18,26Â jt | -1.948,34% |
Tentang
Barinthus Biotherapeutics plc is a biotechnology company developing immunotherapies for infectious diseases, cancer and autoimmune diseases such as hepatitis B, HPV and prostate cancer. Formerly known as Vaccitech plc, in November 2023 the company announced that it had renamed itself to Barinthus Biotherapeutics plc. As of 2024, the company employs more than 100 people. Wikipedia
Didirikan
2016
Situs
Karyawan
130
